Systematic chemical-genetic and chemical-chemical interaction datasets for prediction of compound synergism
暂无分享,去创建一个
Mike Tyers | Emma Griffiths | Gerard D. Wright | Jan Wildenhain | Michaela Spitzer | Sonam Dolma | Nick Jarvik | Rachel White | Marcia Roy | David S. Bellows | M. Tyers | M. Spitzer | J. Wildenhain | D. Bellows | M. Roy | Gerard D. Wright | E. Griffiths | S. Dolma | N. Jarvik | Rachel White
[1] Norbert Haider,et al. Functionality Pattern Matching as an Efficient Complementary Structure/Reaction Search Tool: an Open-Source Approach , 2010, Molecules.
[2] angesichts der Corona-Pandemie,et al. UPDATE , 1973, The Lancet.
[3] M. Tyers,et al. From large networks to small molecules. , 2004, Current opinion in chemical biology.
[4] S. Loewe,et al. Die quantitativen Probleme der Pharmakologie , 1928 .
[5] P. Sorger,et al. Systems biology and combination therapy in the quest for clinical efficacy , 2006, Nature chemical biology.
[6] Jennifer M. Rust,et al. The BioGRID Interaction Database , 2011 .
[7] Anne Mai Wassermann,et al. Dark chemical matter as a promising starting point for drug lead discovery. , 2015, Nature chemical biology.
[8] Mike Tyers,et al. Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole , 2011, Molecular systems biology.
[9] C. I. Bliss. THE TOXICITY OF POISONS APPLIED JOINTLY1 , 1939 .
[10] Gang Fu,et al. PubChem Substance and Compound databases , 2015, Nucleic Acids Res..
[11] Mike Tyers,et al. Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. , 2015, Cell systems.
[12] David S. Wishart,et al. DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..
[13] Robert P. St.Onge,et al. Defining genetic interaction , 2008, Proceedings of the National Academy of Sciences.
[14] Michael Costanzo,et al. Systematic exploration of synergistic drug pairs , 2011, Molecular systems biology.
[15] Charles Boone,et al. Systems-level antimicrobial drug and drug synergy discovery. , 2013, Nature chemical biology.
[16] Gary D Bader,et al. The Genetic Landscape of a Cell , 2010, Science.
[17] W. Greco,et al. The search for synergy: a critical review from a response surface perspective. , 1995, Pharmacological reviews.
[18] Grant W. Brown,et al. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways , 2004, Nature Biotechnology.
[19] Mike Tyers,et al. ALDH2 Mediates 5-Nitrofuran Activity in Multiple Species , 2012, Chemistry & biology.
[20] Yang Xie,et al. A community computational challenge to predict the activity of pairs of compounds Citation , 2015 .
[21] Kara Dolinski,et al. The BioGRID interaction database: 2015 update , 2014, Nucleic Acids Res..
[22] H. Kitano. A robustness-based approach to systems-oriented drug design , 2007, Nature Reviews Drug Discovery.
[23] Jorge Cortes,et al. Systems approaches and algorithms for discovery of combinatorial therapies. , 2009, Wiley interdisciplinary reviews. Systems biology and medicine.
[24] Mike Tyers,et al. MolClass: a web portal to interrogate diverse small molecule screen datasets with different computational models , 2012, Bioinform..
[25] Robert P. St.Onge,et al. The Chemical Genomic Portrait of Yeast: Uncovering a Phenotype for All Genes , 2008, Science.
[26] Asier Unciti-Broceta,et al. A Yeast Chemical Genetic Screen Identifies Inhibitors of Human Telomerase , 2013, Chemistry & biology.
[27] Mike Tyers,et al. Combined zebrafish-yeast chemical-genetic screens reveal gene–copper-nutrition interactions that modulate melanocyte pigmentation , 2010, Disease Models & Mechanisms.
[28] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.